Drug Profile
Genetic disorder therapeutic - Kaleido Biosciences
Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Kaleido Biosciences
- Class
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inborn genetic disorders